| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 654669 | 67919 | ADARTREL 0,25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | ADARTREL 0,25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 12 comprimidos | 0,25 mg | 5 | 12 | 10 | 12 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67919/67919_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67919/67919_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3732 | GLAXOSMITHKLINE S.A. | 2006-07-04 | 1 | 1 | 1 | 2006-07-04 | 2006-07-04 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 659927 | 07417001 | YONDELIS 0,25 mg POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION | YONDELIS 0,25 mg POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial | 0,25 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/07417001/07417001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/07417001/07417001_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 5722 | PHARMA MAR S.A. | 2007-10-08 | 1 | 1 | 1 | 2007-10-08 | 2007-10-08 | 1 | 2012-01-09 | View Edit Delete | ||||||||||||
| 663922 | 61880 | ALPRAZOLAM SANDOZ 0,25 mg COMPRIMIDOS EFG | ALPRAZOLAM SANDOZ 0,25 mg COMPRIMIDOS EFG , 30 comprimidos | 0,25 mg | 5 | 30 | 10 | 30 comprimidos | 1 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61880/61880_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61880/61880_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | SANDOZ FARMACEUTICA S.A. | 1998-05-01 | 1 | 1 | 1 | 1998-05-01 | 1998-05-01 | 1 | 2011-11-15 | Lista IV | View Edit Delete | |||||||||||
| 665224 | 61809 | ALPRAZOLAM VIATRIS 0,25 MG COMPRIMIDOS EFG | ALPRAZOLAM VIATRIS 0,25 MG COMPRIMIDOS EFG, 30 comprimidos | 0,25 mg | 5 | 30 | 10 | 30 comprimidos | 1 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61809/61809_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61809/61809_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38105 | VIATRIS PHARMACEUTICALS S.L. | 1997-12-01 | 1 | 1 | 1 | 1997-12-01 | 1997-12-01 | 1 | 2011-10-24 | Lista IV | View Edit Delete | |||||||||||
| 690563 | 61464 | REQUIP 0,25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | REQUIP 0,25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 84 comprimidos | 0,25 mg | 5 | 84 | 10 | 84 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61464/61464_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61464/61464_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3732 | GLAXOSMITHKLINE S.A. | 1997-07-01 | 1 | 1 | 1 | 1997-07-01 | 2012-05-28 | 1 | 2013-04-12 | View Edit Delete | ||||||||||||
| 700525 | 66001 | CERTICAN 0,25 mg COMPRIMIDOS | CERTICAN 0,25 mg COMPRIMIDOS , 60 comprimidos | 0,25 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/66001/66001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/66001/66001_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1945 | NOVARTIS FARMACEUTICA S.A. | 2004-03-29 | 1 | 1 | 1 | 2004-03-30 | 2015-04-06 | 1 | 2011-10-06 | 873224 | View Edit Delete | |||||||||||
| 700527 | 66002 | CERTICAN 0,25 mg COMPRIMIDOS DISPERSABLES | CERTICAN 0,25 mg COMPRIMIDOS DISPERSABLES, 60 comprimidos | 0,25 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/66002/66002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/66002/66002_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1945 | NOVARTIS FARMACEUTICA S.A. | 2004-03-29 | 1 | 1 | 1 | 2004-03-30 | 2015-04-06 | 1 | 2011-10-06 | 874347 | View Edit Delete | |||||||||||
| 711879 | 64428 | ALPRAZOLAM TARBIS 0,25 mg COMPRIMIDOS EFG | ALPRAZOLAM TARBIS 0,25 mg COMPRIMIDOS EFG, 30 comprimidos | 0,25 mg | 5 | 30 | 10 | 30 comprimidos | 1 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64428/64428_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64428/64428_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | TARBIS FARMA S.L. | 2001-11-30 | 1 | 1 | 1 | 2001-11-30 | 2001-11-30 | 1 | 2011-10-21 | Lista IV | View Edit Delete | |||||||||||
| 716175 | 63279 | ALPRAZOLAM KERN PHARMA 0,25 mg COMPRIMIDOS EFG | ALPRAZOLAM KERN PHARMA 0,25 mg COMPRIMIDOS EFG, 30 comprimidos | 0,25 mg | 5 | 30 | 10 | 30 comprimidos | 1 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63279/63279_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63279/63279_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2000-07-27 | 1 | 1 | 1 | 2000-07-27 | 2003-01-14 | 1 | 2011-10-17 | Lista IV | 895227 | View Edit Delete | ||||||||||
| 714056 | 81556 | ALPRAZOLAM AUROVITAS 0,25 MG COMPRIMIDOS EFG | ALPRAZOLAM AUROVITAS 0,25 MG COMPRIMIDOS EFG, 30 comprimidos | 0,25 mg | 6 | 30 | 10 | 30 comprimidos | 1 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/81556/81556_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/81556/81556_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16109 | AUROVITAS SPAIN, S.A.U. | 2016-12-23 | 1 | 1 | 1 | 2016-12-24 | 2016-12-23 | 1 | 2020-04-08 | Lista IV | View Edit Delete | |||||||||||
| 723967 | 83571 | ALPRAZOLAM KRKA 0.25 MG COMPRIMIDOS EFG | ALPRAZOLAM KRKA 0.25 MG COMPRIMIDOS EFG, 30 comprimidos | 0,25 mg | 5 | 30 | 10 | 30 comprimidos | 1 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/83571/83571_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/83571/83571_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1575 | KRKA FARMACEUTICA S.L. | 2018-11-06 | 1 | 1 | 1 | 2018-11-07 | 2018-11-06 | 1 | 2019-03-01 | Lista IV | View Edit Delete | |||||||||||
| 726297 | 1191377001 | TALZENNA 0,25 MG CAPSULAS DURAS | TALZENNA 0,25 MG CAPSULAS DURAS, 30 cápsulas | 0,25 mg | 6 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1191377001/1191377001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191377001/1191377001_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 29446 | PFIZER S.L. | 2019-07-24 | 1 | 1 | 1 | 2019-07-25 | 2019-07-24 | 1 | 2024-12-13 | View Edit Delete | ||||||||||||
| 727951 | 1191414001 | MAYZENT 0,25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | MAYZENT 0,25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 12 comprimidos | 0,25 mg | 5 | 12 | 10 | 12 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1191414001/1191414001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191414001/1191414001_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 28642 | NOVARTIS FARMACEUTICA S.A. | 2020-02-18 | 1 | 1 | 1 | 2020-02-19 | 2020-02-18 | 1 | 2021-03-10 | View Edit Delete | ||||||||||||
| 729764 | 85564 | LOGNIF 0,25 MG CAPSULAS DURAS EFG | LOGNIF 0,25 MG CAPSULAS DURAS EFG, 28 cápsulas (Blister OPA/AL/PVC//Al) | 0,25 mg | 5 | 28 | 43 | 28 cápsulas (Blister OPA/AL/PVC//Al) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85564/85564_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85564/85564_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2020-11-16 | 1 | 1 | 1 | 2020-11-17 | 2020-11-16 | 1 | 2022-02-15 | View Edit Delete | ||||||||||||
| 732746 | 86540 | ALPRAZOLAM COMBIX 0,25 MG COMPRIMIDOS EFG | ALPRAZOLAM COMBIX 0,25 MG COMPRIMIDOS EFG, 30 comprimidos | 0,25 mg | 5 | 30 | 10 | 30 comprimidos | 1 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86540/86540_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86540/86540_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12564 | LABORATORIOS COMBIX S.L.U. | 2022-02-02 | 1 | 1 | 1 | 2022-02-03 | 2022-02-02 | 1 | 2022-09-14 | Lista IV | View Edit Delete | |||||||||||
| 731838 | 86266 | ALPRAZOLAM TECNIGEN 0,25 MG COMPRIMIDOS EFG | ALPRAZOLAM TECNIGEN 0,25 MG COMPRIMIDOS EFG, 30 comprimidos | 0,25 mg | 5 | 30 | 10 | 30 comprimidos | 1 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86266/86266_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86266/86266_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12947 | TECNIMEDE ESPAÑA INDUSTRIA FARMACEUTICA S.A. | 2021-10-05 | 1 | 1 | 1 | 2021-10-06 | 2021-10-05 | 1 | 2021-11-16 | Lista IV | View Edit Delete | |||||||||||
| 759850 | 88382 | FINGOLIMOD TARBIS 0,25 mg CAPSULAS DURAS EFG | FINGOLIMOD TARBIS 0,25 mg CAPSULAS DURAS EFG, 28 capsulas | 0,25 mg | 5 | 28 | 43 | 28 capsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88382/88382_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88382/88382_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 2876 | TARBIS FARMA S.L. | 2022-12-09 | 1 | 1 | 1 | 2022-12-10 | 2022-12-09 | 1 | 2024-07-12 | View Edit Delete | ||||||||||||
| 760141 | 88407 | TRABECTEDINA SUN 0,25 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSIÓN EFG | TRABECTEDINA SUN 0,25 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSIÓN EFG, 1 vial | 0,25 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88407/88407_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88407/88407_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 8873 | SUN PHARMA LABORATORIOS S.L. | 2022-12-22 | 1 | 1 | 1 | 2022-12-23 | 2022-12-22 | 1 | 2025-01-14 | View Edit Delete | ||||||||||||
| 762908 | 88898 | TRABECTEDINA EVER PHARMA 0,25 MG POLVO PARA CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN EFG | TRABECTEDINA EVER PHARMA 0,25 MG POLVO PARA CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN EFG, 1 vial | 0,25 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88898/88898_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88898/88898_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 23345 | EVER PHARMA THERAPEUTICS SPAIN S.L. | 2023-06-12 | 1 | 1 | 1 | 2023-06-13 | 2023-06-12 | 1 | 2023-09-28 | View Edit Delete | ||||||||||||
| 763747 | 89148 | TRABECTEDINA STADA 0,25 MG POLVO PARA CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN EFG | TRABECTEDINA STADA 0,25 MG POLVO PARA CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN EFG, 1 vial | 0,25 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89148/89148_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89148/89148_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 6220 | LABORATORIO STADA S.L. | 2023-11-13 | 1 | 1 | 1 | 2023-11-14 | 2023-11-13 | 1 | 2024-07-16 | View Edit Delete |
Page 11 of 1036, showing 20 records out of 20704 total, starting on record 201, ending on 220